Trial Profile
A Phase IV European retrospective study of Everolimus in patients with metastatic renal cell carcinoma previously treated with Bevacizumab +/-interferon therapy (AVATOR).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Apr 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- Acronyms AVATOR
- 03 Sep 2015 New trial record